SENATE CONCURRENT RESOLUTION NO. 301
(By Senators Tomblin, Mr. President, Prezioso, Bailey, Boley,
Bowman, Caldwell, Chafin, Deem, Dempsey, Edgell, Facemyer,
Fanning, Guills, Helmick, Hunter, Jenkins, Kessler, Love,
McCabe, McKenzie, Minard, Minear, Oliverio, Plymale, Ross,
Rowe, Sharpe, Snyder, Sprouse, Unger and White)
Authorizing the use or reference of the Federal Supply Schedule
in establishing a benchmark for prescription drug prices for
the negotiation and purchase of brand name drugs by the State
of West Virginia; authorizing the Pharmaceutical Cost
Management Council to implement the strategic plan
established in the Reference Pricing Report submitted on
September 10, 2004, to the Joint Committee on Government and
Finance in accordance with the provisions of article three-c,
chapter five-a of the code of West Virginia, 1931, as
amended; and requesting the Pharmaceutical Cost Management
Council recommend legislative enactments as necessary, from
time to time, to implement the same.
Whereas, In accordance with the provisions of section six-d,
article three-c, chapter five-a of the code, the Pharmaceutical
Cost Management Council has recommended the establishment of a
pricing schedule using or referencing the Federal Supply Schedule as a benchmark for prescription drug prices for the negotiation
and purchase of brand name drugs; and
Whereas, In accordance with the provisions of section six-e,
article three-c, chapter five-a of the code, the adoption of a
concurrent resolution by the Legislature is required to authorize
the use or reference of the Federal Supply Schedule as a benchmark
for prescription drug prices for the negotiation and purchase of
brand name drugs and the implementation of the strategic plan
established in the Reference Pricing Report; therefore, be it
Resolved by the Legislature of West Virginia:
That the Legislature hereby authorizes the use or reference
of the Federal Supply Schedule in establishing a benchmark for
prescription drug prices for the negotiation and purchase of brand
name drugs by the State of West Virginia; and, be it
Further Resolved, That the Legislature hereby authorizes the
Pharmaceutical Cost Management Council to implement the strategic
plan established in the Reference Pricing Report; and, be it
Further Resolved, That the Legislature hereby requests the
Pharmaceutical Cost Management Council to recommend legislative
enactments as necessary, from time to time, to implement the same.